Thrombopoietin-like peptides to speed bone healing and reduce fracture pain
Official title: Thrombopoietin Mimetic Peptides for Treatment of Fractures
Funded at Rlr VA Medical Center · NIH-11118687 · Data updated 2026-11-12
Using thrombopoietin-like peptides to help veterans' bones heal faster and lower pain after fractures.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rlr VA Medical Center NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2028 |
| Funding year | 2025 |
| NIH project number | 5I01BX006399-02 |
| Project ID | NIH-11118687 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults, especially veterans, with recent bone fractures—particularly high-energy lower-extremity injuries—or those at risk for poor healing who can attend follow-up visits.
✕Less likely to help
People without recent fractures, those whose pain stems from other conditions, or those with medical reasons preventing peptide therapy may not benefit.
What this research studies
If I joined this work, researchers would test small protein-like drugs that act like thrombopoietin to see how they affect bone repair and fracture-related pain. They will look at how these peptides influence platelets, bone-forming cells, inflammation, and pain behaviors. The goal is to find a therapy that improves healing while reducing reliance on opioids and NSAIDs. Some experiments may be done in the lab or animal models as part of steps toward treating people.
Why it matters
Potential benefit: Could produce a treatment that speeds bone healing and reduces fracture pain, potentially lowering opioid use and the risk of nonunion.
How similar studies have gone: Prior laboratory studies link thrombopoietin signaling to improved bone repair, but using thrombopoietin-mimetic peptides for fracture healing and pain relief in people is relatively new.
Where this research is happening
-
Rlr VA Medical Center
Indianapolis, United States Active
Researchers
- Principal investigator: Kacena, Melissa a — Rlr VA Medical Center
- Study coordinator: Kacena, Melissa a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.